( NewsNation) — Genetic testing company 23andMe has faced a series of struggles this year, culminating in end-of-year mass ...

Medicine is on the precipice of radical changes in diagnosis, personalised treatment, and the ability to prevent disease ...

o. 23andMe is considered a direct-to-consumer genetic testing company, and transactions with the company are considered ...

Me is to cut 200 jobs in the wake of declining revenues. This company expects a proposed retructuring, affecting 40% of its ...

23andMe, the struggling ancestry tracing company, continues to spiral, raising questions about its business prospects and what could happen to its sensitive customer genetic testing data. CEO Anne ...

According to Research by , Rising Demand for Personalized Health Solutions and Proactive Health Management Drives Robust Growth in Predictive Genetic Testing MarketAustin, Nov. 14, 2024 (GLOBE ...

Meanwhile, Hims & Hers tackles the GLP-1 shortage with a new app; Eli Lilly releases data on tirzepatide efficacy; 23andMe faces privacy concerns; and more.

The financial struggles of genetic testing and ancestry company 23andMe are raising questions about the security of customers ...

Zytronic employs about 110 people at its Tyneside facility which had supplied touch-screens for a broad range of uses - from ...

Me just dropped some major news in a tough year for the genetic testing company. After months of financial challenges, data ...